{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hodgkins-lymphoma","columns":[{"gene":"","key":"population-64af9cb8e1bcd6877682","label":"Hodgkins lymphoma","mondoId":"MONDO:0004952","onsetQualifier":null,"originColumnKey":"MONDO:0004952/no-native-evidence","originalViews":[{"key":"MONDO:0004952/no-native-evidence","label":"Hodgkins lymphoma","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-64af9cb8e1bcd6877682"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-64af9cb8e1bcd6877682"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Hodgkin lymphoma (HL) is a heterogeneous group of malignant lymphoid neoplasms of B-cell origin characterized histologically by the presence of Hodgkin and Reed-Sternberg (HRS) cells in the vast majority of cases.","mondoId":"MONDO:0004952","node":{"canonicalSlug":"hodgkins-lymphoma","comparisons":[{"documentSha256":"887631938b2632c3927ccd7f92c34dc86dad319ac4b26b6d8333ce3d460b1cb6","key":"expanded-epstein-barr-virus-related-tumor","kind":"expanded","label":"Epstein-Barr virus-related tumor","memberIds":["MONDO:0001892","MONDO:0002159","MONDO:0002571","MONDO:0002624","MONDO:0003347","MONDO:0003348","MONDO:0003349","MONDO:0003350","MONDO:0003351","MONDO:0003353","MONDO:0003355","MONDO:0003356","MONDO:0003357","MONDO:0003358","MONDO:0003359","MONDO:0003360","MONDO:0003362","MONDO:0003364","MONDO:0003365","MONDO:0003367","MONDO:0003368","MONDO:0003369","MONDO:0003370","MONDO:0003371","MONDO:0003372","MONDO:0003373","MONDO:0003374","MONDO:0003376","MONDO:0003377","MONDO:0003378","MONDO:0003379","MONDO:0003655","MONDO:0003782","MONDO:0003928","MONDO:0004206","MONDO:0004207","MONDO:0004208","MONDO:0004604","MONDO:0004620","MONDO:0004633","MONDO:0004665","MONDO:0004952","MONDO:0005058","MONDO:0005764","MONDO:0006128","MONDO:0006150","MONDO:0006416","MONDO:0006429","MONDO:0007243","MONDO:0009348","MONDO:0010273","MONDO:0010762","MONDO:0015459","MONDO:0016262","MONDO:0016283","MONDO:0017342","MONDO:0017343","MONDO:0017344","MONDO:0017345","MONDO:0017346","MONDO:0017347","MONDO:0017348","MONDO:0017349","MONDO:0017596","MONDO:0017601","MONDO:0017784","MONDO:0018223","MONDO:0018224","MONDO:0018842","MONDO:0019466","MONDO:0019472","MONDO:0019478","MONDO:0021297","MONDO:0021537","MONDO:0044778","MONDO:0044887","MONDO:0859747","MONDO:0859748","MONDO:0859749"],"mondoId":"MONDO:0017342","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-887631938b2632c3927c.887631938b2632c3927ccd7f92c34dc86dad319ac4b26b6d8333ce3d460b1cb6.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hodgkins lymphoma","originalSourceId":"ORPHA:98293","paragraphs":["Hodgkin lymphoma (HL) is a heterogeneous group of malignant lymphoid neoplasms of B-cell origin characterized histologically by the presence of Hodgkin and Reed-Sternberg (HRS) cells in the vast majority of cases."],"rawAttribution":"MONDO:0004952","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:49Z","upstream":"MONDO:0004952","url":"https://rarediseases.info.nih.gov/diseases/2714"},"ownColumnKeys":["population-64af9cb8e1bcd6877682"],"publication":"published","relationships":[{"kind":"parent","label":"lymphoma","mondoId":"MONDO:0005062","slug":null},{"kind":"parent","label":"Epstein-Barr virus-associated lymphoproliferative disorder","mondoId":"MONDO:0017343","slug":"epstein-barr-virus-associated-lymphoproliferative-disorder"},{"kind":"child","label":"splenic hodgkin lymphoma","mondoId":"MONDO:0006429","slug":null},{"kind":"child","label":"classic Hodgkin lymphoma","mondoId":"MONDO:0009348","slug":"classic-hodgkin-lymphoma"},{"kind":"child","label":"lymphoma, Hodgkin, X-linked pseudoautosomal","mondoId":"MONDO:0010273","slug":null},{"kind":"child","label":"lymphoma, Hodgkin, Y-linked pseudoautosomal","mondoId":"MONDO:0010762","slug":null},{"kind":"child","label":"nodular lymphocyte predominant Hodgkin lymphoma","mondoId":"MONDO:0044778","slug":"nodular-lymphocyte-predominant-hodgkin-lymphoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2714\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0004952\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0004952</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hodgkin lymphoma (HL) is a heterogeneous group of malignant lymphoid neoplasms of B-cell origin characterized histologically by the presence of Hodgkin and Reed-Sternberg (HRS) cells in the vast majority of cases.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2714\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hodgkins-lymphoma","sourceDocuments":[{"name":"GARD: Hodgkins lymphoma","reviewed":null,"source_release":"2026-10-25T03:38:49Z","url":"https://rarediseases.info.nih.gov/diseases/2714"},{"name":"MONDO: Hodgkins lymphoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0004952"}],"sourceNote":"","synonyms":["HL","Hodgkin disease","Hodgkin lymphoma","Hodgkin's Disease","Hodgkin's disease","Hodgkin's lymphoma","Hodgkin's sarcoma","lymphoma, Hodgkin's","stage I subdiaphragmatic Hodgkin lymphoma","stage II subdiaphragmatic Hodgkin lymphoma"],"takeawayHtml":"","title":"Hodgkins lymphoma"},"schemaVersion":1}
